US Stock MarketDetailed Quotes

TriSalus Life Sciences (TLSI)

Watchlist
  • 4.580
  • -0.070-1.51%
Trading Apr 20 13:37 ET
281.28MMarket Cap-2.49P/E (TTM)

TriSalus Life Sciences (TLSI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
53.41%45.15M
59.85%13.21M
57.38%11.57M
52.27%11.21M
41.97%9.17M
58.99%29.43M
44.40%8.26M
41.52%7.35M
59.67%7.36M
116.39%6.46M
Operating revenue
53.41%45.15M
59.85%13.21M
57.38%11.57M
52.27%11.21M
41.97%9.17M
58.99%29.43M
44.40%8.26M
41.52%7.35M
59.67%7.36M
116.39%6.46M
Cost of revenue
69.75%6.97M
44.90%1.76M
89.84%1.91M
97.59%1.8M
53.96%1.5M
57.50%4.1M
108.93%1.22M
70.46%1M
18.13%912K
46.68%971K
Gross profit
50.77%38.19M
62.43%11.44M
52.25%9.66M
45.86%9.41M
39.85%7.67M
59.24%25.33M
37.09%7.05M
37.81%6.35M
68.02%6.45M
136.26%5.49M
Operating expense
5.92%65.13M
0.61%14.71M
23.80%18.67M
14.47%16.74M
-12.57%15M
-12.63%61.49M
-24.56%14.63M
-35.04%15.08M
-4.24%14.63M
37.89%17.16M
Selling and administrative expenses
14.52%50.17M
4.10%12.14M
24.23%13.5M
28.71%12.82M
3.46%11.71M
8.04%43.81M
0.41%11.67M
-20.77%10.87M
18.74%9.96M
66.36%11.31M
-Selling and marketing expense
11.11%28.71M
13.74%7.97M
11.42%6.84M
19.30%7.16M
0.70%6.73M
51.69%25.84M
25.09%7.01M
30.90%6.14M
71.94%6M
105.82%6.69M
-General and administrative expense
19.44%21.46M
-10.42%4.17M
40.87%6.66M
43.00%5.66M
7.43%4.97M
-23.59%17.97M
-22.58%4.66M
-47.62%4.73M
-19.20%3.96M
30.26%4.63M
Research and development costs
-15.39%14.97M
-13.15%2.57M
22.68%5.18M
-15.92%3.92M
-43.60%3.3M
-40.71%17.69M
-61.91%2.96M
-55.62%4.22M
-32.24%4.67M
3.58%5.84M
Operating profit
25.49%-26.95M
56.85%-3.27M
-3.15%-9.01M
10.30%-7.33M
37.21%-7.33M
33.61%-36.17M
46.80%-7.58M
53.06%-8.74M
28.51%-8.17M
-15.32%-11.67M
Net non-operating interest income expense
-85.74%-4.99M
-26.11%-1.28M
-31.10%-1.29M
-65.26%-1.29M
-1,375.28%-1.14M
-747.23%-2.69M
-519.50%-1.01M
-978.57%-984K
-2,537.50%-780K
196.67%89K
Non-operating interest income
37.38%555K
210.53%177K
7.59%170K
38.14%134K
-19.57%74K
-6.26%404K
-76.64%57K
36.21%158K
169.44%97K
162.86%92K
Non-operating interest expense
79.42%5.54M
35.96%1.45M
27.85%1.46M
62.26%1.42M
40,200.00%1.21M
19,212.50%3.09M
35,500.00%1.07M
28,450.00%1.14M
21,825.00%877K
-40.00%3K
Other net income (expense)
-182.67%-7.29M
-243.02%-5.21M
-106.86%-502K
-92.87%330K
-17.65%-1.91M
266.45%8.81M
92.98%-1.52M
-57.13%7.32M
280.89%4.63M
-189.11%-1.62M
Gain on sale of security
-93.93%-4.09M
101.88%11K
-158.95%-2.93M
96.34%-330K
-133.12%-835K
80.59%-2.11M
94.91%-586K
275.70%4.97M
-942.62%-9.02M
4.13%2.52M
Special income (charges)
-124.42%-2.74M
-520.12%-5.15M
6.95%2.52M
-94.89%700K
79.44%-820K
-4.93%11.23M
91.36%-830K
-88.15%2.36M
2,104.35%13.69M
-552.67%-3.99M
-Less:Restructuring and merger&acquisition
124.42%2.74M
520.12%5.15M
-6.95%-2.52M
94.89%-700K
-79.44%820K
-9.11%-11.23M
-91.36%830K
88.14%-2.36M
---13.69M
--3.99M
Other non- operating income (expenses)
-46.15%-456K
30.39%-71K
-623.08%-94K
9.09%-40K
-64.05%-251K
95.01%-312K
79.80%-102K
0.00%-13K
98.96%-44K
89.69%-153K
Income before tax
-30.56%-39.22M
3.52%-9.75M
-349.88%-10.81M
-91.70%-8.29M
21.46%-10.37M
49.39%-30.04M
71.63%-10.11M
-68.56%-2.4M
69.02%-4.33M
-59.59%-13.2M
Income tax
16.67%7K
0
266.67%5K
-142.86%-3K
66.67%5K
-33.33%6K
-200.00%-1K
-3K
-46.15%7K
160.00%3K
Net income
-30.56%-39.23M
3.51%-9.75M
-350.65%-10.81M
-91.32%-8.29M
21.44%-10.38M
49.39%-30.05M
71.64%-10.11M
-68.35%-2.4M
69.00%-4.33M
-59.72%-13.21M
Net income continuous Operations
-30.56%-39.23M
3.51%-9.75M
-350.65%-10.81M
-91.32%-8.29M
21.44%-10.38M
49.39%-30.05M
71.64%-10.11M
-68.35%-2.4M
69.00%-4.33M
-59.72%-13.21M
Minority interest income
Net income attributable to the parent company
-30.56%-39.23M
3.51%-9.75M
-350.65%-10.81M
-91.32%-8.29M
21.44%-10.38M
49.39%-30.05M
71.64%-10.11M
-68.35%-2.4M
69.00%-4.33M
-59.72%-13.21M
Preferred stock dividends
-10.86%714K
-11.11%712K
153.42%3.19M
-2.13%783K
75.33%803K
801K
801K
Other preferred stock dividends
30.46M
0
30.46M
-11.11%712K
0
0
0
-60.39%801K
-16.48%801K
Net income attributable to common stockholders
-109.70%-69.69M
10.45%-9.75M
-1,189.01%-41.27M
-75.38%-9M
20.85%-11.09M
47.75%-33.23M
70.11%-10.89M
-70.05%-3.2M
67.91%-5.13M
-51.80%-14.01M
Basic earnings per share
-40.46%-1.84
47.50%-0.21
-700.00%-0.96
-28.57%-0.27
35.00%-0.39
80.65%-1.31
74.36%-0.4
14.29%-0.12
65.45%-0.21
97.99%-0.6
Diluted earnings per share
-40.46%-1.84
47.50%-0.21
-700.00%-0.96
-28.57%-0.27
35.00%-0.39
80.65%-1.31
74.36%-0.4
14.29%-0.12
65.45%-0.21
97.99%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 53.41%45.15M59.85%13.21M57.38%11.57M52.27%11.21M41.97%9.17M58.99%29.43M44.40%8.26M41.52%7.35M59.67%7.36M116.39%6.46M
Operating revenue 53.41%45.15M59.85%13.21M57.38%11.57M52.27%11.21M41.97%9.17M58.99%29.43M44.40%8.26M41.52%7.35M59.67%7.36M116.39%6.46M
Cost of revenue 69.75%6.97M44.90%1.76M89.84%1.91M97.59%1.8M53.96%1.5M57.50%4.1M108.93%1.22M70.46%1M18.13%912K46.68%971K
Gross profit 50.77%38.19M62.43%11.44M52.25%9.66M45.86%9.41M39.85%7.67M59.24%25.33M37.09%7.05M37.81%6.35M68.02%6.45M136.26%5.49M
Operating expense 5.92%65.13M0.61%14.71M23.80%18.67M14.47%16.74M-12.57%15M-12.63%61.49M-24.56%14.63M-35.04%15.08M-4.24%14.63M37.89%17.16M
Selling and administrative expenses 14.52%50.17M4.10%12.14M24.23%13.5M28.71%12.82M3.46%11.71M8.04%43.81M0.41%11.67M-20.77%10.87M18.74%9.96M66.36%11.31M
-Selling and marketing expense 11.11%28.71M13.74%7.97M11.42%6.84M19.30%7.16M0.70%6.73M51.69%25.84M25.09%7.01M30.90%6.14M71.94%6M105.82%6.69M
-General and administrative expense 19.44%21.46M-10.42%4.17M40.87%6.66M43.00%5.66M7.43%4.97M-23.59%17.97M-22.58%4.66M-47.62%4.73M-19.20%3.96M30.26%4.63M
Research and development costs -15.39%14.97M-13.15%2.57M22.68%5.18M-15.92%3.92M-43.60%3.3M-40.71%17.69M-61.91%2.96M-55.62%4.22M-32.24%4.67M3.58%5.84M
Operating profit 25.49%-26.95M56.85%-3.27M-3.15%-9.01M10.30%-7.33M37.21%-7.33M33.61%-36.17M46.80%-7.58M53.06%-8.74M28.51%-8.17M-15.32%-11.67M
Net non-operating interest income expense -85.74%-4.99M-26.11%-1.28M-31.10%-1.29M-65.26%-1.29M-1,375.28%-1.14M-747.23%-2.69M-519.50%-1.01M-978.57%-984K-2,537.50%-780K196.67%89K
Non-operating interest income 37.38%555K210.53%177K7.59%170K38.14%134K-19.57%74K-6.26%404K-76.64%57K36.21%158K169.44%97K162.86%92K
Non-operating interest expense 79.42%5.54M35.96%1.45M27.85%1.46M62.26%1.42M40,200.00%1.21M19,212.50%3.09M35,500.00%1.07M28,450.00%1.14M21,825.00%877K-40.00%3K
Other net income (expense) -182.67%-7.29M-243.02%-5.21M-106.86%-502K-92.87%330K-17.65%-1.91M266.45%8.81M92.98%-1.52M-57.13%7.32M280.89%4.63M-189.11%-1.62M
Gain on sale of security -93.93%-4.09M101.88%11K-158.95%-2.93M96.34%-330K-133.12%-835K80.59%-2.11M94.91%-586K275.70%4.97M-942.62%-9.02M4.13%2.52M
Special income (charges) -124.42%-2.74M-520.12%-5.15M6.95%2.52M-94.89%700K79.44%-820K-4.93%11.23M91.36%-830K-88.15%2.36M2,104.35%13.69M-552.67%-3.99M
-Less:Restructuring and merger&acquisition 124.42%2.74M520.12%5.15M-6.95%-2.52M94.89%-700K-79.44%820K-9.11%-11.23M-91.36%830K88.14%-2.36M---13.69M--3.99M
Other non- operating income (expenses) -46.15%-456K30.39%-71K-623.08%-94K9.09%-40K-64.05%-251K95.01%-312K79.80%-102K0.00%-13K98.96%-44K89.69%-153K
Income before tax -30.56%-39.22M3.52%-9.75M-349.88%-10.81M-91.70%-8.29M21.46%-10.37M49.39%-30.04M71.63%-10.11M-68.56%-2.4M69.02%-4.33M-59.59%-13.2M
Income tax 16.67%7K0266.67%5K-142.86%-3K66.67%5K-33.33%6K-200.00%-1K-3K-46.15%7K160.00%3K
Net income -30.56%-39.23M3.51%-9.75M-350.65%-10.81M-91.32%-8.29M21.44%-10.38M49.39%-30.05M71.64%-10.11M-68.35%-2.4M69.00%-4.33M-59.72%-13.21M
Net income continuous Operations -30.56%-39.23M3.51%-9.75M-350.65%-10.81M-91.32%-8.29M21.44%-10.38M49.39%-30.05M71.64%-10.11M-68.35%-2.4M69.00%-4.33M-59.72%-13.21M
Minority interest income
Net income attributable to the parent company -30.56%-39.23M3.51%-9.75M-350.65%-10.81M-91.32%-8.29M21.44%-10.38M49.39%-30.05M71.64%-10.11M-68.35%-2.4M69.00%-4.33M-59.72%-13.21M
Preferred stock dividends -10.86%714K-11.11%712K153.42%3.19M-2.13%783K75.33%803K801K801K
Other preferred stock dividends 30.46M030.46M-11.11%712K000-60.39%801K-16.48%801K
Net income attributable to common stockholders -109.70%-69.69M10.45%-9.75M-1,189.01%-41.27M-75.38%-9M20.85%-11.09M47.75%-33.23M70.11%-10.89M-70.05%-3.2M67.91%-5.13M-51.80%-14.01M
Basic earnings per share -40.46%-1.8447.50%-0.21-700.00%-0.96-28.57%-0.2735.00%-0.3980.65%-1.3174.36%-0.414.29%-0.1265.45%-0.2197.99%-0.6
Diluted earnings per share -40.46%-1.8447.50%-0.21-700.00%-0.96-28.57%-0.2735.00%-0.3980.65%-1.3174.36%-0.414.29%-0.1265.45%-0.2197.99%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran ceasefire agreement is set to expire on Wednesday (April 22), with tensions escalating over the weekend. On April 20, the US mil Show More